Hot Life Science Investor Mandate 10: Merchant Bank Seeks Strategic Medtech Opportunities for China Expansion

25 Nov

A Shanghai-based merchant bank has a newly formed office in Cambridge, MA, that sources healthcare investment opportunities for China-based institutional investors. The firm is interested in both acquisitions and minority equity investments; allocations have varied from $30M to $1.5BN, but for healthcare deals the firm prefers to invest $75 million or more in a given opportunity. The firm seeks opportunities in North America and Europe.

The firm is interested in any opportunity in healthcare, but has a particular interest and expertise in medical device opportunities and healthcare service facilities. In the medical device sector, the firm is only interested in companies that have a revenue-generating product, but do not need to be profitable at this time. The firm is interested in all types of medical devices, and has expertise in orthopedics.

The firm’s primary criteria is a strong strategic fit with the firm’s China-based investors, who are seeking to bring the branding and medical expertise of North American or European medical technology companies to the Asia market. The firm is interested, but not exclusively seeking companies that are planning to expand into Asia, or to grow their existing Asia business. The firm is open to investing in companies that have revenues but not profits.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: